Suvretta Capital Management, LLC Kura Oncology, Inc. Transaction History
Suvretta Capital Management, LLC
- $2.33 Billion
- Q1 2024
A detailed history of Suvretta Capital Management, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 7,069,627 shares of KURA stock, worth $146 Million. This represents 6.46% of its overall portfolio holdings.
Number of Shares
7,069,627
Previous 6,946,230
1.78%
Holding current value
$146 Million
Previous $99.9 Million
50.97%
% of portfolio
6.46%
Previous 5.19%
Shares
15 transactions
Others Institutions Holding KURA
# of Institutions
173Shares Held
80.4MCall Options Held
914KPut Options Held
120K-
Black Rock Inc. New York, NY6.9MShares$142 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$120 Million3.53% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$111 Million2.38% of portfolio
-
Bvf Inc San Francisco, CA4.79MShares$98.5 Million3.06% of portfolio
-
State Street Corp Boston, MA4.2MShares$86.5 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.38B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...